Andrew Spaventa, Chief Executive Officer at Singular Genomics Systems, Inc. (OMIC), sold 486 shares at $20.16 ($4K) on 2024-12-16, disclosed to the SEC on 2024-12-17.
Open-market sale of $4k OMIC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 306 | $0 | 0.0% |
| 2 | $20.16 | 180 | $4K | 100.0% |
| Total | $7.47 avg | 486 | $4K | 100% |
| Filing → |
| OMIC | SELL | 2024-09-17 | $2K | — | Filing → |
| OMIC | BUY | 2023-11-20 | $49K | — | Filing → |